CASP3 and osteosarcoma: Dobutamine has been reported for significantly inhibit proliferation, increase apoptosis, induce expression of caspases 3 and 9, arrest the cell cycle at the G2/M transition stage, and reduce migration and invasion of MG-63 osteosarcoma cells in a time- and concentration-dependent manner, thereby [53].